Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Limited long-term data: most evidence is from animal models, with no long-term human study of NNMT inhibition and oncological endpoints
BPC-157's preclinical tissue-repair and joint-recovery literature is the most extensive of any component in either blend, making it the logical anchor for a musculoskeletal recovery formulation
Use appropriate containment if aerosols or biological materials are involved
Results depend on injury type, severity, duration, individual healing capacity, and dosing protocol
Does the Brand Matter
Systemic Inflammation and Post-Injury Recovery For patients with widespread musculoskeletal inflammation, chronic soft tissue pain, or a recent surgical recovery, BPC-157 is most often prescribed as part of the Wolverine Stack, which combines BPC-157 with TB-500 (Thymosin Beta-4) for synergistic tissue repair
